Nucleotide changes in the γ-globin promoter and the (AT)(x)N(y)(AT)(z) polymorphic sequence of βLCRHS-2 region associated with altered levels of HbF

European Journal of Human Genetics

Volumn 7, Issue 3, 1999, Pages 345-356

  Samakoglu, Selda ^a,c   Philipsen, Sjaak ^b   Grosveld, Frank ^b   Lüleci, Güven ^a   Bagci, Hüseyin ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c INSTITUT PASTEUR   (France)

Author keywords

globin gene; globin gene haplotype; thalassaemia; globin genes; mRNA; HBF; HPFH

Indexed keywords

GAMMA GLOBIN; HEMOGLOBIN F; MESSENGER RNA;

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; CONTROLLED STUDY; GENE CLUSTER; GENE CONVERSION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PROMOTER REGION; SCHOOL CHILD;

ADOLESCENT; ADULT; BETA-THALASSEMIA; CHILD; FETAL HEMOGLOBIN; GLOBINS; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

EID: 0032959462     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5200284     Document Type: Article

References (53)

1. Wainscoat JS, Old JM, Weatherall DJ, Orkin SH: The molecular basis for the clinical diversity of β thalassaemia in Cypriots. Lancet 1983b; i: 1235-1237.
2. Wainscoat JS, Kanavakis E, Wood WG et al: Thalassaemia intermedia in Cyprus: the interactions of α and β thalassaemia. Br J Haematol 1983a; 53: 411-416.
3. 0 thalassaemia and the Swiss type of hereditary persistence of foetal haemoglobin. Br J Haematol 1981; 48: 561-572.
4. Perkins AC, Gaensler KM, Orkin SH: Silencing of human foetal globin expression is impaired in the absence of the adult beta-globin gene activator protein EKLF. Proc Natl Acad Sci USA 1996; 93(22): 12267-12271.
5. Kollia P, Noguchi CT, Fibach E, Loukopoulos D, Schechter AN: Modulation of globin gene expression in cultured erythroid precursors derived from normal individuals: transcriptional and posttranscriptional regulation by hemin. Proc Assoc Am Physic 1997; 109(4): 420-428.
6. Langdon SD, Kaufman RE: Gamma globin gene promoter elements required for interaction with globin enhancers. Blood 1998; 91: 1309-1318.
7. Baron MH: Developmental regulation of the vertebrate globin multigene family. Gene Expr 1996; 6(3): 129-137.
8. Jane SM, Cunningham JM: Molecular mechanisms of hemoglobin switching. Int J Biochem Cell Biol 1996; 28(11): 1197-1209.
9. Samakoǧlu S, Baǧci H: Globin gene regulation mediated by the locus control region. Tr J Med Sci 1995; 25: 83-88.
10. Chang YC, Smith KD, Moore RD, Serjeant GR, Dover GJ: An analysis of fetal hemoglobin variation in sickle cell disease: the relative contributions of the X linked factor, β globin haplotypes, α globin gene number, gender and age. Blood 1995; 85: 1111-1117.
11. Merghoub T, Perichon B, Maier-Redelsperger M et al: Dissection of the association status of two polymorphisms in the beta-globin gene cluster with variations in F-cell number in non-anemic individuals. Am J Hematol 1997; 56(4): 239-243.
12. Sampietro M, Thein SL, Contreras M, Pazmany L: Variation of HbF and F cell number with the Gγ -153 Xmn I (C→T) polymorphism in normal individuals. Blood 1992; 79: 832-833.
13. Stamatoyannopoulos G, Wood WG, Papayannopoulou T: A new form of hereditary persistence of fetal hemoglobin in blacks and its association with sickle cell trait. Blood 1975; 46: 683-692.
14. Martinez G, Novelletto A, Di Rienzo A, Felicetti L, Colombo B: A case of hereditary persistence of fetal hemoglobin caused by a gene not linked to the β-globin cluster. Hum Genet 1989; 82: 335-337.
15. Thein SL, Weatheral DJ: A non deletion hereditary persistance of fetal hemoglobin (HPFH) determinant not linked to the β globin gene complex. In: Stamatoyannopoulos G, Nienhuis AW (eds). Hemoglobin Switching, B: Cellular and Molecular Mechanism. Alan Liss: New York, 1989, pp 97-111.
16. Rochette J, Dode C, Leturcq F, Krishnamoorthy R: Level and comparison of fetal hemoglobin expression in normal newborn babies are not dependent on b cluster DNA haplotype. Am J Hematol 1990; 34: 223-224.
17. Stamatoyannopoulos G, Neinhuis AW: Hemoglobin switching. In: Stamatoyannopoulos G, Neinhuis AW, Leder P, Majerus PW (eds). The Molecular Basis of Blood Diseases, WB Saunders: Philadelphia, 1987, pp 66-105.
18. 0 point mutations in cis. Am J Hematol 1994; 45: 81-84.
19. Katsube T, Fukumaki Y: A role for the distal CCAAT box of the gamma-globin gene in Hb switching. J Biochem (Tokyo) 1995; 117(1): 68-76.
20. Stamatoyannopoulos G, Neinhuis AW: Hemoglobin switching. In: Stamatoyannopoulos G, Neinhuis AW, Majerus PW, Varmus H. The Molecular Basis of Blood Diseases (2nd edn). WB Saunders: Philadelphia, 1994, pp 107-155.
21. Old JM, Ayyub H, Wood WG: Linkage analysis of nondeletion hereditary persistence of fetal hemoglobin. Science 1982; 215: 981-982.
22. Dover GJ, Smith KD, Chang YC et al: Fetal hemoglobin levels in sickle cell disease and normal individuals are partially controlled by X linked gene located at Xp 22.2. Blood 1992; 80(3): 816-824.
23. Craig J, Rochette J, Fisher C et al: Dissecting the loci controlling fetal haemoglobin production on chromosomes lip and 6q by the regressive approach. Nat Genet 1996; 12: 58-64.
24. Grosveld F, Dillon N, Higgs D: The regulation of human globin gene expression. In: Higgs DR, Weatherall DJ (eds). Baillière's Clinical Haematology. Baillière Tindall: London, 1993, pp 31-55.
25. Zon LI, Tsai SF, Burgess S, Matsudaira P, Bruns GA, Orkin SH: The major human erythroid DNA binding protein (GF-1): Primary sequence and localization of the gene to the X chromosome. Proc Natl Acad Sci USA 1990; 87: 668-672.
26. Gilman JG, Huisman THJ: DNA sequence variation associated with elevated fetal Gγ globin production. Blood 1985; 66: 783-787.
27. Perichon B, Ragusa A, Lapoumeroulie C et al: Inter-ethnic polymorphism of the β globin gene locus control region (LCR) in sickle cell anemia patients. Hum Genet 1993; 91: 464-468.
28. Kutlar A, Kutlar F, Gu Lg, Mayson SM, Huisman THJ: Fetal hemoglobin in normal adults and β thalassemia heterozygotes. Hum Genet 1990; 85: 106-110.
29. Shelton JR, Selton JB, Schroeder WA: High performance liquid Chromatographic separation of globin chains on a large pore C4 column. J Liq Chromatogr 1984; 7: 1969-1977.
30. Poncz M, Solowiejczyk D, Harpel B, Mory Y, Schwartz E, Surrey S: Construction of human gene libraries from small amounts of peripheral blood. Analysis of β like globine genes. Hemoglobin 1982; 6: 27-30.
31. Orkin SH, Kazazian HH, Antonarakis SE et al: Linkage of β thalassaemia mutations and β globin gene polymorphisms with DNA polymorphisms in human β globin gene cluster. Nature 1982; 296: 627-631.
32. Varawalla NY, Fiches AC, Old JM: Analysis of β globin gene haplotype in Asian Indians: origin and spread of β thalassaemia on the Indian subcontinent. Hum Genet 1992; 90: 443-449.
33. Saiki RK, Gelfand DH, Stoffel S et al: Primer directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487.
34. Liu Q, Sommer SS: Restriction endonuclease fingerprinting (REF): a sensitive method for screening mutations in long contiguous segments of DNA. Biotechniques 1995; 18(3): 470-477.
35. Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463-5467.
36. Basak AN: The molecular basis of β thalassemia in Turkey and prenatal diagnosis by DNA analysis. Tr J Biochem 1993; XVIII(2): 1-20.
37. Dode C, Rochette J, Krishnamoorthy R: Locus assignment of human alpha globin mutations by selective amplification and direct sequencing. Br J Haematol 1990; 76: 275-281.
38. Chomczynski P: A reagent for the single-step simultaneous isolation of RNA, DNA and proteins and cell and tissue sample. Biotechniques 1993; 15: 532-537.
39. Efremov DG, Dimovsky AJ, Sukarova E et al: γ-mRNA and HbF levels in β thalassemia. Br J Haematol 1994; 88: 311-317.
40. De Boer E, Antoniou M, Mignotte V, Wall L, Grosveld F: The human β globin gene promotor; nuclear protein factors and erythroid-specific induction of transcription. EMBO J 1988; 7: 4203-4212.
41. Donald L, Ducksworty J, Eves E et al: A homeodomain protein binds to γ globin gene regulatory sequences. Proc Natl Acad Sci USA 1991; 88: 7318-7322.
42. s chromosomes with five different haplotypes. Blood 1991; 77: 2488.
43. Pissard S, Beuzard Y: A potential regulatory region for the expression of fetal hemoglobin in sickle cell disease. Blood 1994; 84(1): 331-338.
44. Yant SR, Zhu W, Millinoff D, Slightom JL, Goodman M, Gumucio DL: High affinity YY1 binding motifs: identification of two core types (ACAT and CCAT) and distribution of potential binding sites within the human β globin cluster. Nucleic Acids Res 1995; 23: 4353-4362.
45. Loukopoulos D: New therapies for the haemoglobinopathies. J Intern Med Suppl 1997; 740: 43-48.
46. Labie D, Dunda-Belkhoddja O, Rouabhi F, Pagnier J, Ragusa A, Nagel RL: The -158 site 5′ to the Gγ gene and Y expression. Blood 1985; 66: 1463-1465.
47. Ragusa A, Lombardo M, Beldjord C et al: Genetic epidemiology of β thalassemia in Sicily: Do sequences 5′ to the Gγ gene and 5′ to the β gene interact to enhance HbF expression in β thalassemia. Am J Hematol 1992; 40: 199-206.
48. Y motif at -530 5′ to the beta-globin gene in over 40 patients homozygous for various beta-thalassemia mutations. Am J Hematol 1994; 45(1): 51-57.
49. Merghoub T, Perichon B, Maier-Redelsperger M et al: Dissection of the association status of two polymorphisms in the beta-globin gene cluster with variations in F-cell number in non-anemic individuals. Am J Hematol 1997; 56(4): 239-243.
50. Tsuda H, Huang RW, Konishi M et al: A new system that analyzes erythropoietin mediated early signal transduction: Transfection of the c-fos enhancer promoter-luciferase gene into a murine erythroid cell line. Eur J Haematol 1994; 52: 73-79.
51. Nisli G, Kavakli K, Aydinok Y, Oztop S, Cetingul N, Basak N: Recombinant erythropoietin trial in children with transfusion-dependent homozygous beta-thalassemia. Acta Haematol 1997; 98(4): 199-203.
52. Sengupta PK, Lavelle DE, De Simone: The 87 kD Aγ-globin enhancer binding protein is a product of the HOX B2 (HOX 2H) locus. Blood 1994; 83(5): 1420-1427.
53. Wickramasinghe SN, Lee MJ: Evidence that the ubiquitip proteolytic pathway is involved in the degradation of precipitated globin chains in thalassaemia. Br J Haematol 1998; 101(2): 245-250.